// App-Quantinova.ai

1648 : Systemic Sclerosis Auto-antibody Profiles Predict Interstitial Lung Disease Onset but Not Progression

Researchers

Presenter

  • Mianbo Wang

Principal Investigators

  • Marvin Fritzler

  • May Choi

  • Murray Baron

  • Marie Hudson

Medical Centers

  • Jewish General Hospital/ McGill Univeristy, Montreal, QC, Canada

  • Lady Davis Institute, Jewish General Hospital, Montreal, Quebec, Canada.

  • Cumming School of Medicine, University of Calgary, Calgary, AB, Canada

  • Jewish General Hospital/ McGill Univeristy, Montreal, QC, Canada

  • Jewish General Hospital, Lady Davis Institute for Medical Research, McGill University, Montreal, QC, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Autoimmune (AI)

Disease

  • Interstitial lung disease

  • Scleroderma

Biomarkers

  • Forkhead Box C1

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Multicenteric

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A